TAE and UKAEA partner to commercialize advanced fusion technology – New joint venture TAE Beam UK will develop neutral beams for fusion and accelerator innovations for non-fusion applications.
TAE’s Norm machine – the first to produce FRC plasmas with only neutral beam injection – has performed beyond expectations, leapfrogging a planned sixth device, Copernicus
TAE Technologies has raised more than $150 million in its latest funding round, exceeding the company’s initial target for the round. Chevron, Google and NEA participated, among other new and existing investors.
Experimental results published in the peer-reviewed journal Nature Communications prove TAE’s streamlined approach to form and optimize plasma in its Norm machine increases efficiency, significantly reduces complexity and cost, and accelerates the company’s path to net energy and commercial fusion power.
Oxy Low Carbon Ventures (OLCV) and TAE Technologies signed a memorandum to explore using TAE’s fusion technology for emissions-free power and heat in Direct Air Capture (DAC) facilities. The partnership aims to integrate fusion energy with Occidental’s clean energy sources for DAC operations.
Earning the BioTech Breakthrough Award for Oncology Innovation of the Year validates the progress TAE Life Sciences has made in readying its Alphabeam BNCT system for clinical trials worldwide